Self-reported physical functioning and physical fitness in glioma patients.

IF 2.5 Q2 CLINICAL NEUROLOGY
Neuro-oncology practice Pub Date : 2025-07-31 eCollection Date: 2026-02-01 DOI:10.1093/nop/npaf076
Marieke E C Blom, Maxine Gorter, Vera Belgers, Jantine G Röttgering, Philip C de Witt Hamer, Johanna M Niers, Marike R van Lingen, Mona L M Zimmermann, Hans Knoop, Martin Klein, Linda Douw
{"title":"Self-reported physical functioning and physical fitness in glioma patients.","authors":"Marieke E C Blom, Maxine Gorter, Vera Belgers, Jantine G Röttgering, Philip C de Witt Hamer, Johanna M Niers, Marike R van Lingen, Mona L M Zimmermann, Hans Knoop, Martin Klein, Linda Douw","doi":"10.1093/nop/npaf076","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Knowledge about glioma patients' physical functioning and physical fitness throughout the disease trajectory is limited. We analyzed self-reported functioning and fitness in a large sample of glioma patients preoperatively and after primary treatment.</p><p><strong>Methods: </strong>We used the physical functioning subscale of the 36-Item Short Form Health Survey (SF36) and three questions about physical fitness from the Checklist of Individual Strength (CIS20). Scores were compared to age-, sex-, and education-matched population controls, preoperatively and after treatment. In patients with repeated assessments, changes over time were analyzed. Correlations between patient, disease, and treatment characteristics and functioning and fitness at both time points, and with change over time, were explored. Analyses were performed separately for World Health Organization grade II, III, and IV glioma.</p><p><strong>Results: </strong>Grade III patients had significantly lower functioning than controls, both preoperatively and after treatment, and declined over time. No significant differences with controls were found for grade II and IV patients, or for fitness. Grade II patients reported better functioning than grade III and IV preoperatively and better than grade III after treatment. Lower Karnofsky Performance Status was generally related to lower functioning and fitness, while older age, female sex, and lower education appeared in subgroup analyses. Age, neurological disabilities and tumor histology were associated with changes over time.</p><p><strong>Conclusions: </strong>Grade III glioma patients showed poorer functioning than population controls, which declined over time. Grade II patients reported better outcomes than the other subgroups, although individual variability was high. These findings highlight the need for personalized approaches addressing functioning and fitness in glioma.</p>","PeriodicalId":19234,"journal":{"name":"Neuro-oncology practice","volume":"13 1","pages":"149-161"},"PeriodicalIF":2.5000,"publicationDate":"2025-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12965659/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neuro-oncology practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/nop/npaf076","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/2/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Knowledge about glioma patients' physical functioning and physical fitness throughout the disease trajectory is limited. We analyzed self-reported functioning and fitness in a large sample of glioma patients preoperatively and after primary treatment.

Methods: We used the physical functioning subscale of the 36-Item Short Form Health Survey (SF36) and three questions about physical fitness from the Checklist of Individual Strength (CIS20). Scores were compared to age-, sex-, and education-matched population controls, preoperatively and after treatment. In patients with repeated assessments, changes over time were analyzed. Correlations between patient, disease, and treatment characteristics and functioning and fitness at both time points, and with change over time, were explored. Analyses were performed separately for World Health Organization grade II, III, and IV glioma.

Results: Grade III patients had significantly lower functioning than controls, both preoperatively and after treatment, and declined over time. No significant differences with controls were found for grade II and IV patients, or for fitness. Grade II patients reported better functioning than grade III and IV preoperatively and better than grade III after treatment. Lower Karnofsky Performance Status was generally related to lower functioning and fitness, while older age, female sex, and lower education appeared in subgroup analyses. Age, neurological disabilities and tumor histology were associated with changes over time.

Conclusions: Grade III glioma patients showed poorer functioning than population controls, which declined over time. Grade II patients reported better outcomes than the other subgroups, although individual variability was high. These findings highlight the need for personalized approaches addressing functioning and fitness in glioma.

Abstract Image

Abstract Image

Abstract Image

胶质瘤患者自我报告的身体功能和身体健康。
背景:关于胶质瘤患者在整个疾病发展过程中的身体功能和身体健康的知识是有限的。我们分析了大量胶质瘤患者术前和初次治疗后自我报告的功能和健康状况。方法:采用36项健康问卷(SF36)的身体功能量表和《个人力量量表》(CIS20)中的3个体质问题。术前和治疗后,将得分与年龄、性别和教育程度相匹配的人群对照进行比较。在反复评估的患者中,分析随时间的变化。在两个时间点以及随时间的变化,探讨了患者、疾病和治疗特征、功能和适应性之间的相关性。分别对世界卫生组织分级II、III和IV级胶质瘤进行分析。结果:III级患者术前和治疗后的功能明显低于对照组,并随着时间的推移而下降。II级和IV级患者的健康状况与对照组没有显著差异。II级患者术前功能优于III级和IV级,治疗后优于III级。较低的Karnofsky Performance Status一般与较低的功能和健康相关,而年龄较大、女性和受教育程度较低则出现在亚组分析中。年龄、神经功能障碍和肿瘤组织学随时间的变化有关。结论:III级胶质瘤患者的功能比人群对照组差,随着时间的推移而下降。II级患者报告的预后优于其他亚组,尽管个体差异很大。这些发现强调需要个性化的方法来解决胶质瘤的功能和适应性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Neuro-oncology practice
Neuro-oncology practice CLINICAL NEUROLOGY-
CiteScore
5.30
自引率
11.10%
发文量
92
期刊介绍: Neuro-Oncology Practice focuses on the clinical aspects of the subspecialty for practicing clinicians and healthcare specialists from a variety of disciplines including physicians, nurses, physical/occupational therapists, neuropsychologists, and palliative care specialists, who have focused their careers on clinical patient care and who want to apply the latest treatment advances to their practice. These include: Applying new trial results to improve standards of patient care Translating scientific advances such as tumor molecular profiling and advanced imaging into clinical treatment decision making and personalized brain tumor therapies Raising awareness of basic, translational and clinical research in areas of symptom management, survivorship, neurocognitive function, end of life issues and caregiving
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书